2m 2m 2m 2m 2m 2m 2m
APTEVO THERPTCS (APVO)
NASDAQ
$4.91-$0.13 (-2.68%)
Price as of Jun 03, 2026 6:54 PM EDT- $6.1MMarket Cap
- -94.37%1-Year Change
- BiotechnologyIndustry
APTEVO THERPTCS (APVO)
$4.91-$0.13 (-2.68%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 3.1M 0.00% | 3.1M -74.67% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 3.1M 0.00% | 3.1M -74.67% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -14.5M +1.13% | -14.4M -15.95% | -17.1M -4.33% | -17.9M -5.85% | |
Depreciation and Amortization Expense | 240,000 -31.82% | 352,000 -37.92% | 567,000 -37.07% | 901,000 -21.24% | |
Total Operating Expenses | 11.8M +15.14% | 10.2M -13.14% | 11.8M -15.15% | 13.9M -5.61% | |
Operating Profit | -26.3M +6.95% | -24.6M -14.81% | -28.9M +0.83% | -28.6M +33.84% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -600,000 -57.14% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -600,000 -57.14% | |
Total Nonoperating Income and Expense | 345,000 -26.91% | 472,000 -18.34% | 578,000 +114.35% | -4.0M -49.71% | |
Income before Taxes | -27.5M +14.12% | -24.1M +29.38% | -18.6M -365.90% | 7.0M +123.85% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -27.5M +14.12% | -24.1M +38.59% | -17.4M -316.91% | 8.0M +128.21% | |
Net Income from Continuing Operations Applicable to Common | -27.5M +14.12% | -24.1M +29.38% | -18.6M -365.90% | 7.0M +123.85% | |
Basic EPS and Net Income | -87.27 -0.13% | -87.38 +6,053.52% | -1.42 -190.45% | 1.57 +125.86% | |
Diluted EPS and Net Income | -87.27 -0.13% | -87.38 +6,053.52% | -1.42 -190.45% | 1.57 +125.86% | |
Basic Weighted Average Shares | 315,535 +14.27% | 276,137 -97.74% | 12.2M +139.88% | 5.1M +8.80% | |
Diluted Weighted Average Shares | 315,535 +14.27% | 276,137 -97.74% | 12.2M +139.76% | 5.1M +8.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 21.6M +148.10% | 8.7M -48.45% | 16.9M -25.32% | 22.6M -49.75% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 21.6M +148.10% | 8.7M -48.45% | 16.9M -25.32% | 22.6M -49.75% | |
Total Current Assets | 23.1M +116.54% | 10.7M -44.09% | 19.1M -30.54% | 27.4M -47.78% | |
Accumulated Depreciation | 14.1M +1.42% | 13.9M +2.59% | 13.6M +4.35% | 13.0M +6.08% | |
Property and Plant and Equipment and Net | 303,000 -44.20% | 543,000 -39.33% | 895,000 -38.78% | 1.5M -38.55% | |
Total Long-Term Assets | 303,000 -44.20% | 543,000 -39.33% | 895,000 +1,216.18% | 68,000 0.00% | |
Total Assets | 27.2M +74.42% | 15.6M -37.24% | 24.8M -27.39% | 34.2M -39.55% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 2.0M 0.00% | 2.0M -82.86% | |
Total Current Liabilities | 6.0M -2.53% | 6.2M -14.08% | 7.2M -17.02% | 8.7M -74.95% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 1.5M 0.00% | 1.5M -60.72% | |
Total Long-Term Liabilities | 3.8M N/A | 0 -100.00% | 6.9M -9.05% | 7.5M +461.89% | |
Total Liabilities | 9.8M -9.44% | 10.8M -14.14% | 12.6M -22.29% | 16.2M -70.68% | |
Retained Earnings | -275.1M +11.12% | -247.6M +10.80% | -223.4M +8.45% | -206.0M -3.75% | |
Total Stockholders Equity | 17.4M +265.53% | 4.8M -61.09% | 12.2M -32.01% | 18.0M +1,378.13% | |
Total Shares Outstanding | 997,830 -31.58% | 1.5M -92.51% | 19.5M +201.07% | 6.5M +32.02% | |
Cash Flow | |||||
Cash from Operating Activities | -25.6M +7.60% | -23.8M +102.77% | -11.7M -44.20% | -21.0M -3.03% | |
Capital Expenditures | N/A N/A | N/A N/A | 29,000 0.00% | 29,000 -95.93% | |
Cash from Investing Activities | 0 N/A | 0 +100.00% | -29,000 0.00% | -29,000 -95.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 38.5M +146.85% | 15.6M +160.00% | 6.0M +329.28% | -2.6M -110.00% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | -927.36% +0.83% | -919.75% +428.30% | |
Return on Assets | -128.73% +7.85% | -119.36% +102.43% | -58.96% -433.55% | 17.68% +134.21% | |
Return on Equity | -248.81% -12.48% | -284.28% +146.51% | -115.32% -237.85% | 83.66% +126.18% | |
Revenue Growth | N/A N/A | N/A N/A | 0.00% +100.00% | -74.67% -140.30% | |
Current Ratio | 3.82 +122.15% | 1.72 -34.93% | 2.64 -16.29% | 3.15 +108.46% | |
Cash Ratio | 3.57 +154.53% | 1.40 -40.00% | 2.34 -10.00% | 2.60 +100.61% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.28 +47.06% | 0.19 -98.48% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.14 +37.72% | 0.10 -62.81% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow